🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. Lixisenatide (AVE0010)

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule completed

    3 trials

  2. Lotilaner ophthalmic solution, 0.25%

    Tarsus Pharmaceuticals

    Demodex Blepharitis

    approved small molecule completed

    1 trial

  3. Low intensity laser for oral mucositis

    Lxo Ireland Designated Activity Company

    Oral Mucositis

    approved other active

    1 trial

  4. Low-Molecular-Weight Heparins Calcium Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pneumonia

    approved small molecule completed

    1 trial

  5. Lucentis

    Hospital Authority, Hong Kong

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  6. Lutrate Depot Trimestral 22,5 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 150 mg film-coated tablets, Femara 2.5 mg Tablets, Arimidex® 1 mg film-coated tablets, Zoladex 10,8 mg implantat, Aromasil 25 mg comprimidos recubiertos, Verzenios 100 mg film-coated tablets, Zoladex 3,6 mg implantat, Kisqali 200 mg film-coated tablets, Lutrate Depot Mensual 3,75 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 50 mg film-coated tablets

    Ningbo Cancer Hospital

    Early Breast Cancer

    approved small molecule active

    1 trial

  7. METHADONE , Suboxone 2 mg/0.5 mg sublingual tablets

    Disc Medicine

    Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).

    approved small molecule active

    1 trial

  8. METHOTREXATE , MYCOPHENOLIC ACID , AZATHIOPRINE , Tavneos 10 mg hard capsules, CYCLOPHOSPHAMIDE , -, RITUXIMAB, Placebo for AMG 569

    Amgen

    Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)

    approved small molecule active

    1 trial

  9. MIYAIRI 588

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depression Mild

    approved small molecule completed

    1 trial

  10. MORPHINE , EDOXABAN , ENZALUTAMIDE

    Disc Medicine

    Prostate cancer

    approved small molecule active

    1 trial

  11. MUCODRILL 600 mg SANS SUCRE, comprimé effervescent édulcoré au sucralose, FOLINORAL 25 mg, gélule, VITAMINE B12 GERDA 250 microgrammes, comprimé sécable, Omacor 1000 mg capsules molles

    Pari Pharma GmbH

    Ultra High Risk of psychosis and first episode psychosis

    approved small molecule active

    1 trial

  12. Maggot debridement therapy

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcers

    approved other active

    1 trial

  13. Measles-Rubella combined vaccine(MR)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Measles

    approved mab completed

    1 trial

  14. Medtronic Endeavor Resolute

    Rhythm Pharmaceuticals Netherlands B.V.

    Coronary Artery Disease

    approved other completed

    1 trial

  15. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    approved small molecule active

    3 trials

  16. Methotrexate 2,5 mg film-coated tablets, Simponi 50 mg solution for injection in pre-filled syringe., Hydroxychloroquine sulfate 200mg film-coated Tablets, Cimzia 200 mg solution for injection in pre-filled syringe, Depo-Medrol 80 mg/2 ml Injektionssuspension, Leflunomide Aurobindo 20 mg compresse rivestite con film, Enbrel 50 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe, Sulfasalazine 500 mg Tablets, Jyseleca 200 mg film-coated tablets, Kenacort

    Disc Medicine

    Rheumatoid arthritis according to 2010 criteria

    approved small molecule active

    1 trial

  17. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

  18. Methylprednisolone and Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hepatitis

    approved small molecule active

    1 trial

  19. Metronidazole vaginal suppositories

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bacterial Vaginosis

    approved small molecule active

    1 trial

  20. Micafungin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aspergillosis

    approved small molecule terminated

    1 trial

  21. Midodrine Hydrochloride

    Takeda

    Hypotension, Orthostatic

    approved small molecule completed

    2 trials

  22. Mifepristone tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Uterine Fibroid

    approved small molecule terminated

    1 trial

  23. Misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Labor

    approved small molecule active

    1 trial

  24. Mitapivat

    Agios Netherlands B.V.

    Pyruvate Kinase Deficiency

    approved small molecule active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources